Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2

Published:2020-09 Issue: Volume:159 Page:105007
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Chen Yang,Wu Jie,Yan Hongfei,Cheng Yang,Wang Yizhe,Yang Yi,Deng Mingming,Che Xiaofang,Hou Kezuo,Qu Xiujuan,Zou Dan,Liu Yunpeng,Zhang Ye,Hu Xuejun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference59 articles.

1. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening;Smith;CA Cancer J. Clin.,2019

2. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017

3. Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer;Wu;Mol. Cancer,2018

4. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer;Soria;N. Engl. J. Med.,2018

5. Bioinformatics-driven new immune target discovery in disease;Yang;Scand. J. Immunol.,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma;Journal for ImmunoTherapy of Cancer;2024-07

2. Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway;International Journal of Biological Macromolecules;2024-06

3. Revealing the active ingredients and mechanism of P. sibiricumm in non-small-cell lung cancer based on UPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking;Heliyon;2024-04

4. Screening, Identification, and Pigment Characteristics of Actinomycin D-Producing Actinomycetes from Purple Soil in the Sichuan Basin;Jundishapur Journal of Natural Pharmaceutical Products;2024-01-30

5. The Role of the LINC01234/miR-433-3p/GRB2 ceRNA Network in NSCLC Cell Malignant Proliferation;Combinatorial Chemistry & High Throughput Screening;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3